Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme

BACKGROUND AND AIMS: Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of ulcerative colitis. We report integrated analyses of infections in the Phase [P]2 and P3 OCTAVE programmes. METHODS: Three cohorts were analysed: Induction [P2/3 induction studies]; Maintenance [P3 mainten...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Crohns Colitis
Asıl Yazarlar: Winthrop, Kevin L, Loftus, Edward V, Baumgart, Daniel C, Reinisch, Walter, Nduaka, Chudy I, Lawendy, Nervin, Chan, Gary, Mundayat, Rajiv, Friedman, Gary S, Salese, Leonardo, Thorpe, Andrew J, Su, Chinyu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8218715/
https://ncbi.nlm.nih.gov/pubmed/33245746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjaa233
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller